コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 skin pigmentation, nail dystrophy, and oral leukoplakia.
2 helial EBV in the pathogenesis of oral hairy leukoplakia.
3 ufficient for the pathogenesis of oral hairy leukoplakia.
4 e tongue epithelium in lesions of oral hairy leukoplakia.
5 BV-associated diseases other than oral hairy leukoplakia.
6 rting a series of cases of marginal gingival leukoplakia.
7 premalignant lesions, particularly high-risk leukoplakias.
9 ositive subjects with and without oral hairy leukoplakia, a replicative EBV-associated epithelial dis
10 atio (OR) = 0.68, p = 0.0035) and oral hairy leukoplakia (adjusted OR = 0.67, p = 0.033) when compare
11 virus (EBV) replication characterizes hairy leukoplakia, an oral epithelial lesion typically occurri
13 tients with either oral candidiasis or hairy leukoplakia and a low CD4:CD8 cell ratio should be caref
19 and its synthetic derivatives, can eradicate leukoplakia and suppress the formation of squamous cell
22 udy is to raise awareness of this pattern of leukoplakia by reporting a series of cases of marginal g
27 C), pseudomembranous candidiasis (PC), hairy leukoplakia (HL), and warts was computed over follow-up
28 mbrane protein (LMP)-1 is expressed in hairy leukoplakia (HL), but data on LMP-1 sequence variation o
29 deficiency virus (HIV)-associated oral hairy leukoplakia (HLP) and Epstein-Barr virus (EBV) replicati
30 udy, EBV strains were identified in 25 hairy leukoplakia (HLP) biopsies and six matched peripheral bl
31 otein expression in vivo in lesions of hairy leukoplakia (HLP) in which there is abundant EBV replica
35 nails, abnormal skin pigmentation, and oral leukoplakia; Hoyeraal-Hreidarsson syndrome (HH), a clini
38 deficiency virus (HIV)-candidiasis and hairy leukoplakia-in 152 HIV-infected blood transfusion recipi
39 h as nasopharyngeal carcinoma and oral hairy leukoplakia, indicating that the virus can infect epithe
40 f HHV-8 DNA in both the EBV-associated hairy leukoplakia lesions and in the EBV-associated AIDS-relat
41 lytically infected with EBV (from oral hairy leukoplakia lesions) express much more FAS than uninfect
42 EBV was detected by Southern blot in hairy leukoplakia lesions, in a subset of AIDS-related lymphom
43 HIV-positive persons but not in pseudohairy leukoplakia lesions, oral aphthous ulcers, or oral KS le
44 ms to raise awareness that marginal gingival leukoplakia may represent potentially malignant lesions,
45 multisystem disorder, characterized by oral leukoplakia, nail dystrophy, and abnormal skin pigmentat
46 867417 p = 0.02 and rs2240308 p = 0.02), and leukoplakia of oral mucosa is associated with both AXIN2
48 sopharyngeal carcinoma (NPC), and oral hairy leukoplakia (OHL) lesions that have lytic infection, fre
50 gnant disorders (OPMDs), represented by oral leukoplakia (OLK), usually precede head and neck squamou
52 eal involvement (OR, 2.7 [95% CI, 1.8-4.0]), leukoplakia (OR, 2.6 [95% CI, 1.7-3.9]), papilliform sur
53 e due to lytic infection (such as oral hairy leukoplakia) or latent infection (such as nasopharyngeal
56 y malignant disorders (OPMDs)-including oral leukoplakia, oral erythroplakia, oral submucous fibrosis
57 has shown potential in the treatment of oral leukoplakia, oral lichen planus, and head and neck cance
59 eukoplakia, recently coined as proliferative leukoplakia (PL), is associated with a strong tendency t
60 head and neck lesions, such as premalignant leukoplakia progressing to established oral squamous cel
64 al premalignant lesions, we examined 84 oral leukoplakia samples from 37 patients who had been enroll
65 diverse pathologies ranging from oral hairy leukoplakia to nasopharyngeal carcinoma, from infectious